학술논문
Complete Remission Achieved With Single Agent CNTO 328, an Anti–IL-6 Monoclonal Antibody, in Relapsed and Refractory Myeloma
Document Type
Short Communication
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia June 2013 13(3):333-337
Subject
Language
ISSN
2152-2650